Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 2
Results: 10
1
2
Brexpiprazole: A Review in Schizophrenia.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 189, doi. 10.1007/s40265-019-1052-5
- By:
- Publication type:
- Article
3
Fexinidazole: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 215, doi. 10.1007/s40265-019-1051-6
- By:
- Publication type:
- Article
4
Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 173, doi. 10.1007/s40265-018-1048-6
- By:
- Publication type:
- Article
5
Glasdegib: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 207, doi. 10.1007/s40265-018-1047-7
- By:
- Publication type:
- Article
6
Current and Emerging Treatment Strategies for Graves' Orbitopathy.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 109, doi. 10.1007/s40265-018-1045-9
- By:
- Publication type:
- Article
7
Larotrectinib: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 201, doi. 10.1007/s40265-018-1044-x
- By:
- Publication type:
- Article
8
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 161, doi. 10.1007/s40265-018-1043-y
- By:
- Publication type:
- Article
9
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 143, doi. 10.1007/s40265-018-1042-z
- By:
- Publication type:
- Article
10
Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options.
- Published in:
- Drugs, 2019, v. 79, n. 2, p. 125, doi. 10.1007/s40265-018-1039-7
- By:
- Publication type:
- Article